Immature rat uterotrophic assay of diethylstilbestrol, ethynyl estradiol and atrazine

Journal of Toxicologic Pathology

Volumn 13, Issue 3, 2000, Pages 145-149

  Yamasaki, Kanji ^a   Sawaki, Masakuni ^a   Noda, Shuji ^a   Muroi, Takako ^a   Maekawa, Akihiko ^b  

^a CHEMICALS EVALUATION AND RESEARCH INSTITUTE   (Japan)

^b SASAKI INSTITUTE   (Japan)

Author keywords

Atrazine; Diethylstilbestrol; Endocrine; Ethynyl estradiol; Rat; Uterotrophic assay

Indexed keywords

EID: 23044437778     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.13.145     Document Type: Article

References (28)

1. McLachlan JA. Functional toxicology: a new approach to detect functionally active xenobiotics. Environ Health Perspect 1993 ; 101: 386-87.
2. McLachlan JA and Korach KS. Estrogens in the environment III : global health implications. Environ Health Perspect 1995; 103 (Suppl. 7) : 173-78.
3. OECD. OECD guidance and protocol for the prevalidation of the rat uterotrophic screening assay. ENV/JM/TG/ EDTA(99)2/ANN1. Paris: Joint meeting of the chemicals committee and the working party on chemicals, 1999.
4. Ashby J and Tinwell H. Uterotrophic activity of bisphenol A in the immature rat. Environ Health Perspect 1998; 106: 719-20.
5. Branham WS, Sheehan DM, Zehr DR, Medlock KL, Nelson CJ, and Ridlom E. Inhibition of rat uterine gland genesis by tamoxifen. Endocrinology 1985; 117: 2238-48.
6. Branham WS, Zehr DR, Chen JJ, and Sheehan DM. Postnatal uterine development in the rat : estrogen and antiestrogen effects on luminal epithelium. Teratology 1988 ; 38 : 29-36.
7. Branham WS, Zehr DR, and Sheehan DM. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and anti-estrogens. Proc Soc Exp Biol Med 1993 ; 203: 297-303.
8. Odum J, Lefevre PA, Tittensor S, Paton D, Routledge EJ, Beresford NA, Sumpter JP, and Ashby J. The rodent uterotrophic assay : critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Reg Toxicol Pharmacol 1997; 25: 176-88.
9. Reel JR, Lamb JC, and Neal BH. Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam Appl Toxicol 1996; 34: 288-305.
10. Herbst AI, Ulfelder H, and Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal diethylstilbestrol therapy with tumor appearance in young women. N Engl J Med 1971 ; 284: 878-81.
11. Branham WS, Zehr DR, Chen JJ, and Sheehan DM. Alterations in developing rat uterine cell populations after neonatal exposure to estrogens and anti-estrogens. Teratology 1988 ; 38: 271-79.
12. Branham WS, Zehr DR, Chen JJ, and Sheehan DM. Uterine abnormalities in rats exposed neonatally to diethylstilbestrol, ethynylestradiol, or clomiphene citrate. Toxicology 1988 ; 51: 201-12.
13. Iguchi T, Ostrander KT, Mills KT, and Bern HA. Vaginal abnormalities in ovariectomized BALB/cCrgl mice after neonatal exposure to different doses of diethylstilbestrol. Cancer Lett 1988; 43: 207-14.
14. McLachlan JA, Newbold RR, and Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 1980; 40: 3988-99.
15. Medlock KL, Branham WS, and Sheehan DM. Long-term effects of postnatal exposure to diethylstilbestrol on uterine estrogen receptor and growth. J Steroid Biochem Mol Biol 1992; 42: 23-28.
16. Medlock KL, Sheehan DM, Nelson CJ, and Branham WS. Effects of postnatal DES treatment on uterine growth, development, and estrogen receptor levels. J Steroid Biochem Mol Biol 1988; 29: 527-32.
17. Ostrander PL, Mills KT, and Bern HA. Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure. J Natl Cancer Inst 1985 ; 74 : 121-35.
18. Tennant MK, Hill DS, Eldridge, JC, Wetzel LT, Breckenridge CB, and Stevens JT. Possible anti-estrogenic properties ofchloro-s-triazines in rat uterus. J Toxicol Environ Health 1994; 43: 183-96.
19. Tennant MK, Hill DS, Eldridge JC, Wetzel LT, Breckenridge CB, and Stevens JT. Chloro-s-triazine antagonism of estrogen action : limited interaction with estrogen receptor binding. J Toxicol Environ Health 1994; 43: 197-211.
20. Connor K, Howell J, Chen I, Liu H, Berhane K, Sciarretta C, Safe S, and Zacharewski T. Failure of chloro-s-triazinederived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol 1996 ; 30: 93-101.
21. Aso S, Anai M, Noda S, Imatanaka N, Yamasaki K, and Maekawa A. Twenty-eight-day repeated dose toxicity studies of nonylphenol and atrazine for detection of weak endocrine disrupting effects in female rats. J Toxicol Pathol 2000 ; 13 : 13-20.
22. Sawaki M, Yamasaki K, Hoshuyama S, Shinoda K, Kato F, and Shiraishi K. Genital tract development in peripubertal female CD® IGS rats. Comp Med 2000 ; 50 : 284-87.
23. Ing NH and Tornesi MB. Estradiol up-regulates estrogen receptor and progestrone receptor gene expression in specific ovine uterine cells. Biol Reprod 1997; 56: 1205-15.
24. O'Connor JC, Cook JC, Craven SC, Pelt CSV, and Obourn JD. An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. Fundam Appl Toxicol 1996; 33: 182-95.
25. Jordan VC. Biochemical pharmacology and anti-estrogen action. Pharmacol Rev 1984; 36: 245-76.
26. Stack G, Korach KS, and Gorski J. Relative mitogenic activities of various estrogens and anti-estrogens. Steroids 1988; 54: 227-43.
27. Gibson MK, Nemmers LA, Beckman WC, Davis VL, Curtis SW, and Lorach KS. The mechanism of ICI-614,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 1991 ; 129: 2000-10.
28. Certa H, Fedtke N, Wiegand HJ, Muller AMF, and Bolt HM. Toxicokinetics of p-tert-octylphenol in male Wistar rats. Arch Toxicol 1996; 171: 112-22.